Who Paid My Doc
VENTANA PD-L1 (SP263) Assay
Device Tissue Diagnostics
PDI 04015630972784
General payments
$267,203
Research payments
$6,610,888
Through program year 2025, $267,203 in general payments and $6,610,888 in research payments were reported against VENTANA PD-L1 (SP263) Assay (Tissue Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,005,657 | 84 |
| 2024 | Research | $1,131,520 | 48 |
| 2023 | General | $45 | 2 |
| 2023 | Research | $993,811 | 46 |
| 2022 | General | $71,614 | 3 |
| 2022 | Research | $897,270 | 54 |
| 2021 | General | $195,544 | 10 |
| 2021 | Research | $582,629 | 43 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
15 general · 275 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.